Xbrane Biopharma AB (publ) (STO: XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.185
+0.004 (2.44%)
Nov 29, 2024, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 276.53 million as of December 3, 2024. Its market cap has decreased by -50.53% in one year.
Market Cap
276.53M
Enterprise Value
416.30M
Revenue
199.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 276.53M, an increase of 111.00%. That is a compound annual growth rate of 8.82%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,281.98B |
| Swedish Orphan Biovitrum AB (publ) | 103.85B |
| Sectra AB (publ) | 54.85B |
| Getinge AB (publ) | 46.43B |
| Camurus AB (publ) | 33.52B |
| Vitrolife AB (publ) | 30.44B |
| Medicover AB (publ) | 26.39B |
| Elekta AB (publ) | 24.85B |